Scholarly article on 2,2'-diphenyl-2,2'-oxy-di-acetic acid bis-diallylamide 103097-73-0 from Journal of the American Chemical Society p. 6123,6124

DOI: 10.1021/ja01604a047

Source and publish data:

Journal of the American Chemical Society p. 6123,6124 (1956)

Update date:2022-08-05

Topics:

Authors:

Schlesinger

Prill Prill

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1021/ja01604a047

Full text of DOI:10.1021/ja01604a047

Products guided by the article

Product name:2,2'-diphenyl-2,2'-oxy-di-acetic acid bis-diallylamide

Cas No:103097-73-0

R&D Labs maybe for 103097-73-0

H&Y International Group Ltd

Contact:+86-571-86491666

Address:SHI XIANG ROAD
Shandong Xingshun New Material Co., Ltd.

website:http://www.sd-xingshun.com

Contact:+86-519-86461196

Address:Middle of Luhua East Road, Dingtao District
BrightGene Bio-Medical Technology Co., Ltd.

website:https://en.bright-gene.com/

Contact:+86-512-62551801

Address:Building C25 - C31, No. 218 Xinghu Road, Suzhou Industrial Park, Suzhou, Jiangsu, China.
Xinji City Taida Sinopec Co., Ltd.

Contact:0086-311-85341278

Address:No.6, Nanhua Road,Xinji City Road,Hebei Province,China
HANGZHOU ZHONGCHANG SCIENTIFIC CO.,LTD

Contact:+86-571-88932183

Address:Hangzhou

Relevant to this article

A pairwise chemical genetic screen identifies new inhibitors of glucose transport

Doi:10.1016/j.chembiol.2010.12.015
(2011)
2,6-Diaryl-4-acylaminopyrimidines as potent and selective adenosine A_2A antagonists with improved solubility and metabolic stability

Doi:10.1016/j.bmcl.2008.09.048
(2008)
Free radical scavenging abilities of flavonylthiazolidine-2,4-dione compounds

Doi:10.1002/bio.1176
(2011)
Asymmetric organocatalysis: An efficient enantioselective access to benzopyranes and chromenes

Doi:10.1002/chem.200800836
(2008)
Synthesis, human telomerase inhibition and anti-proliferative studies of a series of 2,7-bis-substituted amido-anthraquinone derivatives

Doi:10.1016/j.bmc.2008.05.072
(2008)
Novel purine and pyrazolo[3,4-d]pyrimidine inhibitors of PI3 kinase-α: Hit to lead studies

Doi:10.1016/j.bmcl.2009.11.051
(2010)

Article Doi

DOI: 10.1021/ja01604a047